AAV Vector Validation

AAVnerGene provides comprehensive AAV Validation services to support AAV-based gene therapy and research programs from early discovery through preclinical development. Robust vector validation is essential to ensure accurate dosing, consistent performance, and reliable interpretation of in vitro and in vivo results. Our validation workflows are designed to characterize both vector quality and biological function, helping you move forward with confidence.

Why AAV Vector Validation Matters?

Many AAV-related publications are difficult or even impossible to reproduce, and one of the major underlying reasons is variation in AAV vector quality. AAV preparations can differ significantly from lab to lab and from batch to batch, even when the same serotype, transgene, and protocol are used. Differences in production systems, plasmid quality, cell lines, transfection reagents, culture conditions, and purification methods can all lead to substantial variability in vector potency, purity, and biological performance.

Without rigorous AAV vector validation, researchers may unknowingly compare results generated with vectors that differ in genome integrity, full-to-empty capsid ratio, impurity levels, or functional activity. These hidden differences often result in inconsistent in vitro and in vivo outcomes, misleading dose–response relationships, and poor reproducibility across studies. Comprehensive AAV vector validation is therefore essential not only for ensuring experimental reliability, but also for improving data transparency, cross-study comparability, and long-term translational success.

Our AAV Vector Validation Capabilities

1. Vector Genome & Capsid Titration

  • Quantification of vector genome (VG) titer by qPCR or ddPCR

  • Capsid titer determination by Elisa

  • Analysis of full-to-empty capsid particle ratios my MP

  • Evaluation of batch-to-batch consistency

2. AAV Infectious Titer (TCID50)

  • Measurement of infectious titer to assess functional AAV vector particles with our AAV-Q platform.

3. AAV Genome Integrity & Identity

  • Verification of genome identity and integrity by NGS or ddPCR

  • Detection of truncated, rearranged, or otherwise aberrant genomes

4. Impurity & Safety Screening

  • Residual DNA detection, including plasmid, helper virus, and host cell DNA

  • Quantification of empty capsid content

  • Screening for replication-competent AAV (rcAAV) contamination 

5. In Vitro Transgene Expression Validation

  • Analysis of transgene expression using fluorescent or luciferase reporters

  • RNA expression quantification via qPCR

  • Protein expression validation by Western blot, immunostaining or flow

  • Cell-type–specific expression assays, when applicable

6. In Vivo Biodistribution Studies

  • Assessment of vector distribution and tissue targeting in different animal models (mice, rats, NPHs)

7. Dose & Route Optimization

  • Evaluation and optimization of dosing regimens and administration routes across a variety of disease models to maximize efficacy and safety.

Why Choose AAVnerGene for AAV Validation?

1. Deep AAV Expertise
With over a decade of hands-on experience in AAV vector design, production, and characterization, AAVnerGene understands the critical factors that determine AAV quality, performance, and reproducibility.

2. Comprehensive, End-to-End Validation
We offer a complete suite of AAV validation assays—from vector genome and capsid titration to genome integrity, impurity screening, transgene expression, biodistribution, and dose optimization—ensuring your vectors are fully characterized before in vivo or clinical studies.

3. Reproducibility You Can Trust
A major reason AAV-related studies fail to reproduce is variability in vector quality. AAVnerGene emphasizes batch-to-batch consistency testing and standardized workflows to deliver reliable, comparable, and reproducible results.

4. Advanced Analytical Platforms
We leverage state-of-the-art technologies, including qPCR/ddPCR, cell-based functional assays, NGS-based genome integrity analysis, and in vivo biodistribution profiling, to provide accurate and actionable data.

5. Quality & Safety Focus
Our validation services include impurity profiling (residual DNA, empty capsids), rcAAV screening, and safety-related assessments critical for preclinical development and IND-enabling studies.

6. Biologically Relevant Functional Validation
Beyond physical titers, we validate functional performance through infectious titer assays, in vitro transgene expression, cell-type–specific testing, and in vivo studies in relevant disease models.

7. Flexible, Research-Driven Support
Whether you are optimizing a novel capsid, validating a research-grade vector, or preparing for preclinical studies, our services are customizable to your project goals, timelines, and budgets.

8. Built by AAV Developers, for AAV Developers
AAVnerGene is not just a testing service—we actively develop AAV production platforms and capsid technologies. This practical insight allows us to interpret data in context and provide meaningful recommendations, not just raw numbers.